Navigation Links
Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses

ent in the off-label patient arm (p=0.048). The TVR rate for on-label patients was 4.5 percent versus 11.6 percent in the off- label patient arm (p=0.040). "These findings are consistent with the overall clinical evidence, which shows complex patients to have higher event rates based on their complexity," he said.

The MATRIX Registry also tracked patient outcomes with dual anti-platelet therapy. According to the results, 75 percent of the patients included in the registry adhered to a prescribed dual antiplatelet therapy out to one year. However, such compliance did not result in significant differences in the rates of mortality, heart attack or stent thrombosis after one year compared to the outcomes of patients who stopped dual anti-platelet therapy before one year.

About the CYPHER(R) Stent

The CYPHER(R) Stent has been chosen by cardiologists worldwide to treat approximately three million patients with coronary artery disease. The safety and efficacy of the device is supported by a robust clinical trial program that includes more than 70 studies that examine the performance of the CYPHER(R) Stent in a broad range of patients.

Developed and manufactured by Cordis Corporation, the CYPHER(R) Stent is currently available in more than 80 countries and has the broadest clinical experience and longest-term clinical follow-up of any drug-eluting stent. The next version of sirolimus-eluting stent, the CYPHER(R) SELECT(TM) Sirolimus-eluting Coronary Stent, was launched in Europe, Asia Pacific, Latin America and Canada in 2003. The CYPHER(R) SELECT(TM) Plus Stent, the third version of a sirolimus-eluting coronary stent, received CE Mark in 2006 and is currently available in many markets outside the United States.

For more complete information on indications, contraindications, warnings and precautions, see the Instructions for Use available at www.cypherstent.com.

About Cord
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
2. Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stents Positive Clinical Profile
3. Monitoring Patient Glucose Levels: New Advances in software make it easier
4. Managing Preanalytical Processes for Patient Safety
5. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
6. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:8/22/2014)... 22, 2014 Research and Markets ... Chinese Intravenous Catheter Industry Report 2014" report to ... Intravenous Catheter Industry Report 2014 is a professional and ... intravenous catheter industry with a focus on the Chinese ... the industry including definitions, classifications, applications and industry chain ...
(Date:8/22/2014)... Aug. 22, 2014  Mark Riccio, director of ... facility, is using the online crowd-funding platform Kickstarter ... imaging to researchers and would-be superheros everywhere: "for ... would YOU do if you had Superman,s X-ray ... and explorers everywhere, from elementary through high school ...
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
Breaking Medicine Technology:Global and Chinese Intravenous Catheter Industry Report 2014 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... Jan. 26, 2011 QPS, LLC, a leading full-service ... preclinical and clinical research and development, announced the acquisition ... a full service phase 1 CRO headquartered in Hyderabad, ... QPS is a global CRO supporting drug discovery and ...
... FORT WORTH, Texas, Jan. 26, 2011 Wound Management ... an emerging leader in advanced wound care solutions, announced ... provider, Secure eHealth will be included in a technology ... Conference February 21st-24th at the Orange County Convention Center ...
Cached Medicine Technology:QPS Expands Phase 1 and Bioanalytical Capability by Acquisition of Bioserve, India 2Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase 2Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase 3Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase 4
(Date:8/22/2014)... Jose, CA (PRWEB) August 22, 2014 ... now offering a new teeth whitening technique. Air polishing ... regular cleaning appointments. , Dark teeth can be caused ... two categories: external stains and internal stains. External stains ... stains can be caused by certain medications, such as ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The regional ... Toyota Indiana is on the grow again. ... jobs by summer 2016 to boost production of the ... bring Toyota Indiana’s overall investment to $4 billion. This ... America while providing additional flexibility to adjust its product ...
(Date:8/22/2014)... The LSU Health New Orleans School of Nursing ... grant to increase access to advanced nursing education ... groups, as well as veterans. The Health Resources ... Health and Human Services awarded the two-year grant. ... grant,s project director., The Advanced Education Nursing Traineeship ...
(Date:8/22/2014)... 2014 Millennium Treatment Group, a ... FL, recently launched a new website. Patients, parents, ... can now find Millennium Treatment Group at ... live at the beginning of July. Everything anyone ... be found on the website. There’s an About ...
(Date:8/22/2014)... Mi40x , the latest guide from expert bodybuilder ... they can use a simple 4-minute trick to pack on ... has caught the attention of Shane Michaels, prompting an investigative ... well-known bodybuilders in the industry, and if he uses this ... itself is a testament to how effective this program really ...
Breaking Medicine News(10 mins):Health News:Japantown Dental Introduces Air Polishing 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Millennium Treatment Group Has a New Website 2Health News:Mi40x: Review Exposes Ben Pakulski’s Guide to Packing on Lean Muscle Fast 2
... and practice is needed to achieve dignified care for older ... ,The welfare of older people who live in care homes ... McMurdo and Miles Witham at the University of Dundee. ... to dignity, but people of all ages have a fundamental ...
... indicated that the culprit to most health threat is the ... and heating. According to the UN 5% of the preventable ... ,This study is based on a new estimate ... the physical, chemical, and biological characteristics of air in the ...
... a health drink, but new studies have revealed that coffee can ... some kind of cancers too. Some experts believe that it can ... liver. ,Antioxidants in coffee help control the cell ... is also a source of chlorogenic acid, which has been shown ...
... state representatives from 105 countries met Friday to formally adopt ... of global warming after five days of heated debate to ... ended at 3:30 a.m. Friday," said Carloa Traverso Saibante, information ... ,Once the IPCC report is formally adopted, it ...
... drug manufacturers- Merck &Co. //The issue in contention is the ... no call to charge as much as 1.59 US dollars ... for the same. , Negotiations between Merck and ... declared the drug a ‘public interest’ one. This means that ...
... the activities of farmers from dawn to dusk. But there ... has not been on their side to assist them with ... capricious. ,Indonesia’s rice farming had continued undisturbed for generations, even ... now, it appears that something odd has struck Indonesia. ...
Cached Medicine News:Health News:Major Change Needed to Achieve Dignified Care for Older People 2Health News:New Health Drink—Coffe 2Health News:Climate Talks Reach Consensus in Bangkok 2Health News:Brazil Government In Contention With Merck Over Anti-AIDS Drug 2
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Medicine Products: